171 related articles for article (PubMed ID: 8934361)
1. A comparison of the hypotensive and hypoglycaemic actions of an angiotensin converting enzyme inhibitor, an AT1a antagonist and troglitazone.
Chen S; Noguchi Y; Izumida T; Tatebe J; Katayama S
J Hypertens; 1996 Nov; 14(11):1325-30. PubMed ID: 8934361
[TBL] [Abstract][Full Text] [Related]
2. Bradykinin may not be involved in improvement of insulin resistance by angiotensin converting enzyme inhibitor.
Chen S; Kashiwabara H; Kosegawa I; Ishii J; Katayama S
Clin Exp Hypertens; 1996 Jul; 18(5):625-36. PubMed ID: 8781750
[TBL] [Abstract][Full Text] [Related]
3. Effects of an angiotensin II receptor antagonist, TCV-116, on insulin sensitivity in fructose-fed rats.
Shimamoto K; Matsuda K; Takizawa H; Higashiura K; Ura N; Iimura O
Blood Press Suppl; 1994; 5():113-6. PubMed ID: 7889192
[TBL] [Abstract][Full Text] [Related]
4. Effects of angiotensin receptor antagonist and angiotensin converting enzyme inhibitor on insulin sensitivity in fructose-fed hypertensive rats and essential hypertensives.
Iimura O; Shimamoto K; Matsuda K; Masuda A; Takizawa H; Higashiura K; Miyazaki Y; Hirata A; Ura N; Nakagawa M
Am J Hypertens; 1995 Apr; 8(4 Pt 1):353-7. PubMed ID: 7619347
[TBL] [Abstract][Full Text] [Related]
5. The effects of an angiotensin-converting enzyme inhibitor and an angiotensin II receptor antagonist on insulin resistance in fructose-fed rats.
Higashiura K; Ura N; Takada T; Li Y; Torii T; Togashi N; Takada M; Takizawa H; Shimamoto K
Am J Hypertens; 2000 Mar; 13(3):290-7. PubMed ID: 10777034
[TBL] [Abstract][Full Text] [Related]
6. Troglitazone and metformin, but not glibenclamide, decrease blood pressure in Otsuka Long Evans Tokushima Fatty rats.
Kosegawa I; Chen S; Awata T; Negishi K; Katayama S
Clin Exp Hypertens; 1999 Apr; 21(3):199-211. PubMed ID: 10225476
[TBL] [Abstract][Full Text] [Related]
7. Effects of troglitazone and temocapril in spontaneously hypertensive rats with chronic renal failure.
Yoshida K; Kohzuki M; Xu HL; Wu XM; Kamimoto M; Sato T
J Hypertens; 2001 Mar; 19(3):503-10. PubMed ID: 11288821
[TBL] [Abstract][Full Text] [Related]
8. Metabolic effects of troglitazone on fructose-induced insulin resistance in the rat.
Lee MK; Miles PD; Khoursheed M; Gao KM; Moossa AR; Olefsky JM
Diabetes; 1994 Dec; 43(12):1435-9. PubMed ID: 7958495
[TBL] [Abstract][Full Text] [Related]
9. Evidence against a role of insulin in hypertension in spontaneously hypertensive rats. CS-045 does not lower blood pressure despite improvement of insulin resistance.
Katayama S; Abe M; Kashiwabara H; Kosegawa I; Ishii J
Hypertension; 1994 Jun; 23(6 Pt 2):1071-4. PubMed ID: 8206597
[TBL] [Abstract][Full Text] [Related]
10. Effect of troglitazone (CS-045) and bezafibrate on glucose tolerance, liver glycogen synthase activity, and beta-oxidation in fructose-fed rats.
Inoue I; Takahashi K; Katayama S; Harada Y; Negishi K; Itabashi A; Ishii J
Metabolism; 1995 Dec; 44(12):1626-30. PubMed ID: 8786734
[TBL] [Abstract][Full Text] [Related]
11. Effect of antihypertensive treatment with alacepril on insulin resistance in diabetic spontaneously hypertensive rats.
Sato T; Nara Y; Kato Y; Yamori Y
Metabolism; 1996 Apr; 45(4):457-62. PubMed ID: 8609831
[TBL] [Abstract][Full Text] [Related]
12. Effect of troglitazone, a new oral antidiabetic agent, on fructose-induced insulin resistance.
Yagi N; Takasu N; Higa S; Ishikawa K; Murakami K; Mimura G
Horm Metab Res; 1995 Oct; 27(10):439-41. PubMed ID: 8575720
[TBL] [Abstract][Full Text] [Related]
13. Effect of troglitazone on vascular and glucose metabolic actions of insulin in high-sucrose-fed rats.
Santuré M; Pitre M; Nadeau A; Bachelard H
Metabolism; 2003 Aug; 52(8):978-86. PubMed ID: 12898461
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the metabolic effects of metformin and troglitazone on fructose-induced insulin resistance in male Sprague-Dawley rats.
Chen CC; Wang HJ; Shih HC; Sheen LY; Chang CT; Chen RH; Wang TY
J Formos Med Assoc; 2001 Mar; 100(3):176-80. PubMed ID: 11393112
[TBL] [Abstract][Full Text] [Related]
15. Dietary fat-induced increase in blood pressure and insulin resistance in rats.
Yoshioka S; Uemura K; Tamaya N; Tamagawa T; Miura H; Iguchi A; Nakamura J; Hotta N
J Hypertens; 2000 Dec; 18(12):1857-64. PubMed ID: 11132611
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II type-1 receptor antagonist as well as angiotensin converying enzyme inhibitor attenuates the development of heart failure in aortocaval fistula rats.
Nishikimi T; Tani T; Ohmura T; Yamagishi H; Yanagi S; Yoshiyama M; Toda I; Teragaki M; Akioka K; Takeuchi K
Jpn Circ J; 1995 Nov; 59(11):754-61. PubMed ID: 8747765
[TBL] [Abstract][Full Text] [Related]
17. Effects of chronic inhibition of ACE and AT1 receptors on glomerular injury in dahl salt-sensitive rats.
Otsuka F; Yamauchi T; Kataoka H; Mimura Y; Ogura T; Makino H
Am J Physiol; 1998 Jun; 274(6):R1797-806. PubMed ID: 9841488
[TBL] [Abstract][Full Text] [Related]
18. Regional hemodynamic effects of candesartan cilexetil (TCV-116), an angiotensin II AT1-receptor antagonist, in conscious spontaneously hypertensive rats.
Kanagawa R; Wada T; Sanada T; Ojima M; Inada Y
Jpn J Pharmacol; 1997 Mar; 73(3):185-90. PubMed ID: 9127812
[TBL] [Abstract][Full Text] [Related]
19. Role of angiotensin II in high fructose-induced left ventricular hypertrophy in rats.
Kobayashi R; Nagano M; Nakamura F; Higaki J; Fujioka Y; Ikegami H; Mikami H; Kawaguchi N; Onishi S; Ogihara T
Hypertension; 1993 Jun; 21(6 Pt 2):1051-5. PubMed ID: 8505091
[TBL] [Abstract][Full Text] [Related]
20. Troglitazone improves insulin-stimulated glucose utilization associated with an increased muscle glycogen content in obese Zucker rats.
Oshida Y; Kako M; Nakai N; Shimomura Y; Li L; Sato J; Ohsawa I; Sato Y
Endocr J; 1999 Oct; 46(5):723-30. PubMed ID: 10670760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
